Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Cancer Immunol Res. 2015 Nov 20;4(2):157–164. doi: 10.1158/2326-6066.CIR-15-0165

Figure 5. Normal serum CA125 and/or anti-CA125 positive at time of diagnosis are correlated with increased OvCa patient survival.

Figure 5

Patients with survival data (n = 9 for Stage I/II, n = 50 for Stage III) were divided into groups based on CA125 (normal <35 IU/mL) and/or anti-CA125 (median cutoff), or compared to remaining patients. Kaplan-Meier survival curves were generated using all patients or Stage III patients only. P-values are reported for Log-rank test and median survival time is indicated for each group.